-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive loss of motor neurons in the brain, brainstem, and spinal cord
.
This can lead to progressive muscle weakness and weight loss
Cerebrospinal fluid (CSF) and neurofilaments (Nfs) in the blood have been shown to reflect the degree of motor neuron degeneration and predict the survival rate of patients with ALS (pALS)
Three neuroinflammation markers with good performance at the diagnostic and prognostic level of ALS were selected: chitotriosidase (CHIT1), chitinase 3-like protein 1 (YKL-40) and monocyte chemotactic protein (MCP) -1)
This article was published in " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry ) This article was published in " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry ) This article was published in theJournal of Neurology, Neurosurgery & Psychiatry(Journal of Neurology, Neurosurgery & Psychiatry)
PALS patients were recruited in two centers
.
Including sporadic ALS (sALS), ALS caused by repeated amplification of C9orf72 (C9-ALS) and asymp-C9
Similar results were also found when pNfH was combined with YKL-40 (Supplementary Figure 1 online)
The combination of NfL and YKL-40 levels predicts the survival rate of patients with amyotrophic lateral sclerosis
to further explore the relationship between these biomarkers in predicting survival, and incorporate these biomarkers into a model that contains eight established models Prognostic factors (medullary and non-bulbar onset, age of onset, presence of clear ALS, delay in diagnosis, forced vital capacity, progression rate, frontotemporal dementia (FTD) and the presence of repeat expansion of C9orf72
.
When included in this model, The increased level is independently related to the shorter survival rate of each biomarker
In short, although CHIT1 levels have a better correlation with Nfs, YKL-40 has the most significant added value to Nfs to predict the survival of pALS
MasroriP ,De SchaepdryverM ,FloeterMK MasroriPMasrori De SchaepdryverMDe Schaepdryver FloeterMKFloeter, et alJournal of Neurology, Neurosurgery & PsychiatryPublished Online First:15 December 2021.
Published Online First: doi:10.
1136/jnnp-2021- 327877doi:leave a message here